ERBA Diagnostics Mannheim GmbH
acquires a majority stake in US based IVD company Ivax Diagnostics, Inc.

IVAX Diagnostics Inc. (www.ivaxdiagnostics.com), headquartered in Miami, Florida and listed on the NYSE Amex is a fully integrated In vitro diagnostics company that develops, manufactures and distributes in the United States and internationally, proprietary diagnostic reagents, test kits and instrumentation, for Autoimmune and Infectious diseases, through its three subsidiaries: Diamedix Corporation (U.S.), Delta Biologicals S.r.l. (Italy), and ImmunoVision, Inc. (U.S.) 

This comes within a year of Erba’s acquisition in September 2009 of Erba Lachema s.r.o, a leading diagnostic company in Europe and Russia.

The synergy thus created will help Erba to offer unique Immunodiagnostic innovations in its Products, Procedures and in the development of Integrated Instrument and Reagent systems for both Autoimmune and Infectious Disease detection. The Product Portfolio is also expanded to include Immunoenzymatic and Immunoflourescence assays for Autoimmunity, Microbiology and Allergy panels.

This new basket of US FDA approved, wide spectrum, or progressive products from Erba is definitely an added advantage which will benefit customers with high quality and affordable prices.

http://www.ivaxdiagnostics.com/